Delivery Order SPE2DB20D1100-SPE2DB25FC6F4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $17,313.29. The order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $11,371.30, with a completion date of June 11, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $13,924.72. The award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count supply) under a firm fixed-price contract valued at $11,743.92. The award, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract valued at $15,640.97. The delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $10,908.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets in a 90-count package. This firm fixed-price delivery order, issued on July 28, 2025, is expected to be completed by July 29, 2025. The award represents a non-competitive set-aside contract executed through AmerisourceBergen's existing indefinite delivery vehicle with DLA Troop Support Medical. The product will be delivered to the contractor's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price arrangement. The contract, valued at $1,592.99, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award represents a non-competitive delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $1...
- The Defense Logistics Agency awarded a delivery order valued at $22,131.79 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price, competitive award carries an ultimate completion date of August 21, 2025, and represents a child delivery order under AmerisourceBergen's broader contract vehicle with DLA. The contract is not set-aside and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity, with a ceiling value of $7,604.31 and a firm fixed price contract type. This delivery order, which is non-set-aside and competitively awarded, is set to be completed by June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $1,924.95. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6F4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $15,289.31. The award, issued on June 2, 2025, with completion targeted for June 3, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. This delivery order was competitively awarded with no set-aside designation, and performance is based at the contractor's corporate office location in Conshohocken, Pennsylvania. This award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military and veteran healthcare systems. The Jardiance order exemplifies the company's role in delivering brand-name pharmaceutical products across multiple therapeutic domains, including diabetes management medications, to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 6/2/25 |